Healthcare Market Research Reports and Trends

Renal cancer commonly known as kidney cancer originates in the lining of the proximal convoluted tubule of the kidney. The renal cancer is caused by Von Hippel-Lindau (VHL) syndrome, obesity, smoking, high blood pressure, long-term dialysis, occupational exposure (for example asbestos workers). The symptoms of renal cancer include a lump or mass in the abdomen or side, blood in the urine, weight loss, fever, and lethargy. Several drugs for the treatment of renal cancer are currently available in the market. The global  renal cancer drug market  is likely to show significant growth during the forecast period. This is attributed to the rising incidences of renal cancer, increasing geriatric population, and approval of novel molecules to develop drugs. However, high prices of branded drugs to treat cancer and rising preference for generic drugs are expected to restrain the market for renal cancer drugs market. Categories of Renal Cancer Drugs  The renal cancer drugs market is segm

Fueled by the growing focus on esthetics, preventive dental care, and technological advancements, the dental CAD/CAM systems and consumables industry has experienced significant growth in the past decade. The pivotal factors in the growth of this market are the growing edentulous population, rising incidences of teeth loss due to oral diseases, increase in disposable incomes, growing desire for better aesthetics, and rising demand for advanced dental solutions.  The increasing awareness of dental care, rising demand for the painless treatments, and minimal chair time further propels for  dental CAD/CAM systems market  and consumables. The application of CAD/CAM technology in dentistry has provided several advantages, such as reduced treatment times and increased digitalization leading to greater precision. This has led to a significant increase in the CAD/CAM milling procedures in both dental laboratories and general practice settings. However, the high cost of dental solutions a

The growth of this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare. This report segments the  home healthcare market  into product, service, software, telehealth solutions, and region. Based on product, the market is segmented into testing, screening, & monitoring products; therapeutic products; and mobility care equipment. The mobility care segment is slated to register the highest CAGR during the forecast period due to the growing geriatric population, ease of use, rising demand for personal independence, and social connectedness. These devices also offer personal security and safety. Based on service, the market is segmented into rehabilitation services, infusion therapy services, unskilled care services, respiratory therapy services, pregnancy

The global inspection machines market is projected to reach USD 396.4 Million by 2021, at a CAGR of 5.9% from 2016 to 2021. The prominent drivers of this market are the growing number of regulatory mandates to maintain compliance with current Good Manufacturing Practices (cGMPs), increased product recalls, growing adoption of automated inspection systems, and rising number of inspection checkpoints in the production line. On the other hand, the sales of used and refurbished equipment encroaching on new unit business is a major restraint for market growth. The global  inspection machines market  is mainly segmented on the basis of product, packaging type, machine type, end user, and region. On the basis of product, the market is segmented into seven segments vision inspection systems, leak detection systems, X-ray inspection systems, metal detectors, checkweighers, software, and other inspection systems (carbon dioxide, oxygen, and pressure/moisture inspection systems). In 2015, the

Major factors driving growth of this market include technological advancements such as CBCT, increasing aging populations leading to growth in oral diseases, rising oral care awareness and increasing disposable income in emerging economies, growth impetus of cosmetic dentistry, and shift towards digital dental imaging systems. However, high cost of instruments, lack of reimbursement especially in emerging economies, and lack of dental laboratory technicians are expected to restrain the growth of this market. The global dental imaging market is expected to reach $2,686.5 million by 2019 from $1,691.1 million in 2014, growing at a CAGR of 9.7% from 2014 to 2019. The market by method is bifurcated into extraoral imaging and intraoral imaging. The extraoral imaging market is poised to witness the highest growth in the market,owing to the larger application areas of high end dental imaging systems. The market, by end user is divided into into dental clinics, dental laboratories, denta

The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%.  The market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018. The large share of this segment can be attributed to the increasing penetration of dental implants and the wide applications of metallic biomaterials in dentistry. The market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market. Th

The biomaterials market is projected to reach USD 149.17 Billion by 2021 from USD 70.90 Billion in 2016, at a CAGR of 16.0%. The growth of the overall market can be attributed to increased funds & grants by government bodies worldwide, the growing implantable devices market, technological advancements, rising number of hip and knee replacement procedures, and high growth in geriatric population coupled with growing incidence of cardiovascular diseases. This report segments the  biomaterials market  based on type of material, application, and region. On the basis of type of material, the metallic biomaterials segment is expected to account for the largest share of the global market, in 2016; owing to their unique properties such as biocompatibility, strength, and resistance to breakage, which makes them suitable for usage in various medical applications such as orthopedic, cardiovascular, wound healing, and dentistry. The polymeric biomaterials segment is projected to grow at th

The global  vaccine adjuvants market  is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5% from 2016 to 2021. The major factors driving the growth of this market are high prevalence of infectious and zoonotic diseases, increasing focus on immunization programs by various government bodies, and growing focus on improved and long-lasting immunization against existing and emerging diseases. Based on applications, the global vaccine adjuvants market is segmented into research and commercial applications. Research applications are expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by factors such as increasing need for better immunization for the increasing geriatric population and increasing government funding in research to meet the unmet needs for safe and effective vaccine adjuvants. On the basis of application categories, the vaccine adjuvants market is segmented

Mice models are indispensable tools in research activities with their capability to elucidate human disease processes, due to striking similarities between the anatomy, physiology, and genetics of humans and mice. These advantages promote scientific discovery, understanding of the functions of individual genes, mechanisms of different diseases, and the effectiveness and toxicities of various drug molecules. Mice models are the most popularly used animal models due to their small size, short generation time, accelerated lifespan, low cost, and requirement of less space. These factors help in accelerating the research and development of drug therapies. Knock out Mice Model  are produced by inactivating/silencing or "knocking out" an existing gene and replacing it with an artificial piece of DNA, thereby resulting in the loss of gene activity. This leads to changes in the mouse's phenotypic characteristics, such as appearance, behavior, and other observable biochemical c

The growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. By product, the  in vitro fertilization market  is categorized into reagents and equipment. Reagents are further segmented into cryopreservation media, semen processing media, ovum processing media, and embryo culture media. Embryo culture media is expected to hold the largest share of the IVF reagents market and is also projected to grow at the highest rate during the forecast period. The large share of this segment is attributed to the increase in awareness of infertility treatment and diagnosis. The equipment segment is further classified into imaging systems, sperm separation systems, cabinets (workstations), ovum aspiration pumps, incubators, micromanipulator systems, cryosystems, gas analyzers, laser analyz

Body composition analysis is the process to evaluate the amount of fat, muscle, and bone in the body. It gives the precise measurement of body fat in relation to lean body mass. Evaluation of body composition is essential in order to determine the risks associated with high or low levels of body fat. The growth of the overall body composition analyzers market can be contributed to rise in obese population across the globe, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements. In the coming years, the body composition analyzers market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global body composition analyzers market. However, inconsistency in the accuracy of different analyzers and high cost of equipment is likely to restrain the growth of the market during the forecast period. The   b

The market is segmented into surgical treatment, traumatic & laceration injury treatment, sport & burn injury treatment, ulcer treatment, and treatment of other injuries and wounds. The ulcer treatments segment is expected to grow at the fastest rate during the forecast period, due to the rising number of patients with ulcers due to growth in the diabetic population. Report broadly segments the  medical tapes and bandages market  into product type, end user, application, and region. By product type, the market is categorized into medical tapes and bandages. In 2016, the medical bandages segment accounted for the largest share of the market. This can be attributed to the high number of surgical procedures, increasing aging population, and a rise in medical conditions which require surgical intervention. Based on end users, the market is categorized into hospitals, clinics, ambulatory surgical centers, and homecare setting. The hospitals segment accounted for the major shar

Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. The global respiratory drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period.  The  respiratory drug delivery market , based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles. Based on applications, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory the

The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). The kits segment is projected to grow at the highest CAGR between 2018 and 2024. Growth in this  immunoprecipitation market  can be attributed to factors such as the requirement for repeat purchase of kits, coupled with the increasing number of IP assays to isolate and purify antigens. The individual IP segment is projected to grow at the highest rate in the market, by type. The increasing use of IP in studying protein-protein interactions, to detect the presence of an antigen, and to determine the relative quantity of an antigen are driving the use of individual IP in various research studies during the forecast period. The Asia Pacific is estimated to grow at the highest CAGR

Major factors driving growth of this market include technological advancements such as CBCT, increasing aging populations leading to growth in oral diseases, rising oral care awareness and increasing disposable income in emerging economies, growth impetus of cosmetic dentistry, and shift towards digital dental imaging systems. However, high cost of instruments, lack of reimbursement especially in emerging economies, and lack of dental laboratory technicians are expected to restrain the growth of this market. North America dominates the dental imaging market with the U.S. accounting for a major market share. However, Asia-Pacific is poised to grow at the highest CAGR during the forecast period owing to rising awareness about oral health care, increasing disposable income in this region, and rising focus of prominent players on the APAC market increasing product availability. The  dental imaging market  is segmented into X-ray systems, dental CBCT, intraoral cameras and dental

Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. The ligation devices market is segmented into handheld instruments and accessories. The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period. This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets. The  ligation devices market   is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America dominated the market in 2018, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC region is largely driven by the large patient population and increasing infrastructural

Major factors driving the growth of this market include growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments may restrain the growth of this market. North America dominated the global  cardiac surgery instruments market  in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market. Followed by North America, Europe dominated the global market in 2017. The European market is mainly driven by increasing adoption of surgical procedures in cardiology, growth in European healthcare sector, and awareness programs. However, the Asian market is slated to g

Market growth is primarily driven by the growing incidence of peripheral vascular diseases, growing geriatric population, and increasing preference for minimally invasive surgeries. The global  peripheral vascular devices market  is segmented by type and region. By type, the peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other peripheral vascular devices. The angioplasty stents segment is estimated to account for the largest market of the global peripheral vascular devices market in 2017. The hemodynamic flow alteration devices market is further classified into embolic protection devices and chronic total occlusion devices. The embolic protection devices segment is estimated to account for the largest share of the global hemodynamic flow alteration devices market. The large share

Market include the large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices. The market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segment s,  the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Vascular closure devices market  are relatively high-priced devices compared to manual compression devices. A combination of bott